Commodore Capital LP boosted its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 6.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 610,000 shares of the biotechnology company’s stock after buying an additional 35,000 shares during the period. Arrowhead Pharmaceuticals accounts […]
Commodore Capital LP grew its stake in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 6.1% during the second quarter, Holdings Channel.com reports. The fund owned 610,000 shares of the biotechnology company’s stock after purchasing an additional 35,000 shares during the quarter. Arrowhead Pharmaceuticals makes up 2.4% of Commodore Capital LP’s investment portfolio, making the […]
Commodore Capital LP boosted its position in shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN – Free Report) by 35.6% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 2,348,272 shares of the company’s stock after acquiring an additional 616,907 shares during the quarter. Enliven Therapeutics comprises […]
Commodore Capital LP purchased a new position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 775,000 shares of the company’s stock, valued at approximately $18,212,000. IDEAYA Biosciences comprises approximately […]
Commodore Capital LP increased its position in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 112.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,675,000 shares of the company’s stock after purchasing an additional 885,000 shares during the quarter. Akero Therapeutics comprises approximately 8.8% of Commodore Capital LP’s portfolio, making the stock […]